Login
← Go Back
JFL Life Sciences
JFLLIFE · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 14, 2025
Stock Price vs Company Growth
1d
0.0%
1w
4.9%
1m
19.5%
3m
35.7%
6m
9.6%
1y
3.5%
all
7.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 12.6 0%
8.7
14.4
Company Overview
Sales
131 Cr
Growth: 86.3%
Profit after Tax
6.77 Cr
Growth: 5.7%
Micro Cap
41.4 Cr
P/E: 6.1x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 131
Growth 86.3%
EBITDA 9.1%
P/S 0.3x
Dividend 0.0%
P/E 6.1x
Book Value ₹ 14.2
PEG Ratio 0.1x
ROE 15.1%
P/B 0.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
JFL Life Sciences manufactures a wide range of pharmaceutical formulations. The company’s major products types are Dry powder injections; Tablets & Capsules (B-Lactam) solid oral dosage form; Tablet and capsules (General); and Oral Rehydration Solutions (ORS). Major Events and Milestones2010: The company was incorporated as a private limited company under the name JFL Life Sciences Private Limited.
Belongs to (1 Indices)